Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
- 31 March 2009
- journal article
- pet ct-of-lung-cancer
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 91 (3) , 386-392
- https://doi.org/10.1016/j.radonc.2009.03.006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical studyRadiotherapy and Oncology, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901Journal of Clinical Oncology, 2007
- The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancerEuropean Journal Of Cancer, 2007
- Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyBritish Journal of Cancer, 2006
- Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureLung Cancer, 2005
- Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancerEuropean Journal Of Cancer, 2005
- Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer ResectionJournal of Clinical Oncology, 2004
- Sample size tables for exact single‐stage phase II designsStatistics in Medicine, 2001
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992